Mercados españoles cerrados en 4 hrs 22 min

NovaBay Pharmaceuticals, Inc. (NBY)

NYSE American - NYSE American Precio demorado. Divisa en USD
Añadir a la lista de favoritos
0,0893+0,0003 (+0,34%)
Al cierre: 04:00PM EDT
0,0857 -0,00 (-4,03%)
Antes de la apertura: 06:40AM EDT

NovaBay Pharmaceuticals, Inc.

2000 Powell Street
Suite 1150, eleventh floor
Emeryville, CA 94608
United States
510 899 8800
https://novabay.com

Sector(es)Healthcare
SectorBiotechnology
Empleados a tiempo completo24

Ejecutivos clave

NombreTítuloPagaEjecutadoAño de nacimiento
Mr. Justin M. Hall Esq.President, CEO, General Counsel, Chief Compliance Officer, Corporate Secretary & Director364,15kN/A1978
Mr. Tommy LawController, Interim CFO & Treasurer177,7kN/A1985
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

NovaBay Pharmaceuticals, Inc. develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health. The company also provides wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. It sells its products through the company's web stores, third-party online retailers and distribution partners. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Gobierno corporativo

El ISS Governance QualityScore de NovaBay Pharmaceuticals, Inc., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.